
CRL P/E Ratio
P/E Ratio as of Jul 1, 2025: -237.54
Average-226.82
Median-228.31
Minimum-237.54
Maximum-207.75
-237.54
Past Month-28.88 (13.84%)
The P/E ratio for CRL is -237.54 as of Jul 1, 2025. This represents a decrease of -306.54% compared to its 12-month average P/E ratio of 115.01. A higher P/E ratio suggests that investors expect strong future earnings growth, while a lower P/E ratio may indicate a potentially undervalued stock or slowing growth.
Charles River Laboratories P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
Charles River Laboratories’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing Charles River Laboratories to industry peers.
Charles River Laboratories P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
Charles River Laboratories’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing Charles River Laboratories to industry peers.
CRL P/E Ratio Insights
See Charles River Laboratories’s latest P/E ratio, historical trends, and valuation insights with AI-powered fundamental data and custom analysis.
Start investing in CRL
Order type
Buy in
Order amount
Est. shares
0 shares
CRL P/E Ratio Historic Data
Date | Stock price | P/E ratio |
---|---|---|
Jul 1, 2025 | $154.40 | -237.54 |
Jun 2, 2025 | $135.04 | -207.75 |
May 1, 2025 | $116.89 | 455.71 |
Apr 1, 2025 | $145.99 | 569.16 |
Mar 3, 2025 | $163.50 | 637.43 |
Feb 3, 2025 | $161.62 | 19.96 |
Jan 2, 2025 | $182.64 | 22.55 |
CRL End of Year P/E Ratio
Date | P/E ratio | Change |
---|---|---|
2025 | -237.54 | -1,142.30% |
2024 | 22.79 | -11.01% |
2023 | 25.61 | -0.16% |
2022 | 25.65 | -48.24% |
2021 | 49.56 | +42.70% |
2020 | 34.73 | — |
FAQs About Charles River Laboratories (CRL) P/E ratio
The latest P/E ratio of CRL is -237.54, as of Jul 1, 2025. This is calculated based on its current stock price and earnings per share (EPS).
Charles River Laboratories’s last 12-month average P/E ratio is 115.01, compared to its current P/E ratio of -237.54. This reflects a decrease of -306.54%.
Charles River Laboratories’s current P/E ratio of -237.54 is lower than its last 12-month average P/E of 115.01. A higher P/E can indicate strong future growth expectations, while a lower P/E might suggest undervaluation.
Charles River Laboratories’s average P/E ratio over the last 3 years is 54.25. Comparing this to the current P/E helps assess recent valuation trends and whether the stock is trading above or below its mid-term historical range.
Charles River Laboratories’s average P/E ratio over the last 5 years is 49.2. A deviation from this historical average may indicate shifts in growth expectations, profitability, or broader market conditions affecting valuation.